Abstract
The extracellular calcium-sensing receptor (CaR) is usually associated with systemic Ca(2+) homeostasis, but the CaR is also expressed in many other tissues, including pancreatic islets of Langerhans. In the present study, we have used human islets and an insulin-secreting cell line (MIN6) to investigate the effects of CaR activation using the calcimimetic R-568, a CaR agonist that activates the CaR at physiological concentrations of extracellular Ca(2+). CaR activation initiated a marked but transient insulin secretory response from both human islets and MIN6 cells at a sub-stimulatory concentration of glucose, and further enhanced glucose-induced insulin secretion. CaR-induced insulin secretion was reduced by inhibitors of phospholipase C or calcium-calmodulin-dependent kinases, but not by a protein kinase C inhibitor. CaR activation was also associated with an activation of p42/44 mitogen-activated protein kinases (MAPK), and CaR-induced insulin secretion was reduced by an inhibitor of p42/44 MAPK activation. We suggest that the beta-cell CaR is activated by divalent cations co-released with insulin, and that this may be an important mechanism of intra-islet communication between beta-cells.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aniline Compounds / pharmacology*
-
Antibodies, Monoclonal / pharmacology
-
Benzylamines / pharmacology
-
Calcium / metabolism
-
Calcium / pharmacology
-
Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
-
Carbazoles / pharmacology
-
Cell Communication
-
Cell Line
-
Cells, Cultured
-
Estrenes / pharmacology
-
Extracellular Fluid / metabolism*
-
Flavonoids / pharmacology
-
Glucose / pharmacology
-
Humans
-
Immunohistochemistry
-
Indoles / pharmacology
-
Insulin / metabolism*
-
Insulin Secretion
-
Insulin-Secreting Cells / drug effects
-
Insulin-Secreting Cells / metabolism*
-
Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
Mitogen-Activated Protein Kinases / immunology
-
Mitogen-Activated Protein Kinases / metabolism
-
Phenethylamines
-
Propylamines
-
Protein Kinase C / antagonists & inhibitors
-
Protein Kinases / metabolism*
-
Pyrrolidinones / pharmacology
-
RNA, Messenger / analysis
-
Receptors, Calcium-Sensing / antagonists & inhibitors
-
Receptors, Calcium-Sensing / immunology
-
Receptors, Calcium-Sensing / metabolism*
-
Reverse Transcriptase Polymerase Chain Reaction
-
Staurosporine / pharmacology
-
Stimulation, Chemical
-
Sulfonamides / pharmacology
-
Type C Phospholipases / antagonists & inhibitors
Substances
-
Aniline Compounds
-
Antibodies, Monoclonal
-
Benzylamines
-
Carbazoles
-
Estrenes
-
Flavonoids
-
Indoles
-
Insulin
-
N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine
-
Phenethylamines
-
Propylamines
-
Pyrrolidinones
-
RNA, Messenger
-
Receptors, Calcium-Sensing
-
Sulfonamides
-
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
-
Go 6976
-
KN 93
-
Protein Kinases
-
Protein Kinase C
-
Calcium-Calmodulin-Dependent Protein Kinases
-
Mitogen-Activated Protein Kinases
-
Type C Phospholipases
-
Staurosporine
-
Glucose
-
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
-
Calcium